Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment
04 nov. 2021 06h39 HE
|
Biomerica, Inc.
Studies show that 13-20% of Canadians suffer from IBS at any given time1. The lifetime risk for a Canadian to develop IBS is 30%1. IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc....
Biomerica Launches New Website for Its Aware® Breast Exam Device
29 oct. 2021 08h19 HE
|
Biomerica, Inc.
Simple at-home breast exam device provides results within minutesStudies show increase in Breast Exam Sensitivity IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA)...
Walmart to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Screening Test
19 oct. 2021 06h39 HE
|
Biomerica, Inc.
Over 4,600 Walmart Stores to sell the EZ Detect™ productSimple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) --...
Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021
15 oct. 2021 06h39 HE
|
Biomerica, Inc.
Revenues up 10% over fiscal first quarter 2021, and 20% over fiscal fourth quarter 2021 Customer orders backlog of over $1.5 million at August 31, 2021 Following close of first fiscal quarter...
Walmart Now Selling Biomerica’s EZ Detect™ Colorectal Screening Test
01 oct. 2021 06h39 HE
|
Biomerica, Inc.
Simple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced...
Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week
30 août 2021 08h19 HE
|
Biomerica, Inc.
Final patients to compete this double blinded trial by end of October. Top-Line trial results expected by year end.The InFoods® IBS Diagnostic-Guided Therapy is the first therapy of its kind for...
Biomerica Reports Fiscal 2021 Year End Results
27 août 2021 20h37 HE
|
Biomerica, Inc.
Revenues increase 7.6% for fiscal 2021 vs fiscal 2020.InFoods® IBS Endpoint Trial expected to be fully enrolled in less than 2 weeks.Biomerica receives multiple notices of allowance for patents...
Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression
11 août 2021 08h19 HE
|
Biomerica, Inc.
Hundreds of millions of people worldwide suffer from depression IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has...
Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test
05 août 2021 08h19 HE
|
Biomerica, Inc.
Digital Health Advertising and Social Media Campaigns launching alongside new siteCurrently in discussion with major retailers to increase distribution of EZ Detect™ Colon Disease Test IRVINE,...
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori) Test, hp+detect™
24 juin 2021 08h19 HE
|
Biomerica, Inc.
Prevalence of H. pylori infection in the United States is approximately 35% to 40% of the population IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced...